nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—Retinal toxicity—Cisplatin—esophageal cancer	0.0914	0.17	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—esophageal cancer	0.041	0.0884	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—CYP1B1—esophageal cancer	0.0262	0.0565	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.0256	0.0553	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—NFE2L2—esophageal cancer	0.0251	0.0541	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.0205	0.0442	CbGpPWpGaD
Deferiprone—Fibrosis—Cisplatin—esophageal cancer	0.0193	0.0359	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—NFE2L2—esophageal cancer	0.0178	0.0385	CbGpPWpGaD
Deferiprone—Papilloedema—Cisplatin—esophageal cancer	0.0173	0.0323	CcSEcCtD
Deferiprone—Urine color abnormal—Capecitabine—esophageal cancer	0.0172	0.0321	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—ALDH3A1—esophageal cancer	0.0163	0.0351	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—HMOX1—esophageal cancer	0.0149	0.0322	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—BLVRB—esophageal cancer	0.0145	0.0313	CbGpPWpGaD
Deferiprone—Fibrosis—Capecitabine—esophageal cancer	0.0142	0.0265	CcSEcCtD
Deferiprone—UGT1A6—Oxidative Stress—SOD2—esophageal cancer	0.014	0.0301	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.0136	0.0294	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—CYP1B1—esophageal cancer	0.0124	0.0267	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—PRDX1—esophageal cancer	0.0123	0.0266	CbGpPWpGaD
Deferiprone—Trismus—Capecitabine—esophageal cancer	0.0122	0.0227	CcSEcCtD
Deferiprone—UGT1A6—Phase II conjugation—GSTO1—esophageal cancer	0.0119	0.0257	CbGpPWpGaD
Deferiprone—Chromaturia—Capecitabine—esophageal cancer	0.0114	0.0212	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—SLC39A6—esophageal cancer	0.011	0.0237	CbGpPWpGaD
Deferiprone—Fibrosis—Methotrexate—esophageal cancer	0.0106	0.0197	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—ADH7—esophageal cancer	0.0105	0.0226	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	0.00963	0.0208	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTT1—esophageal cancer	0.00923	0.0199	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—ADH7—esophageal cancer	0.00919	0.0198	CbGpPWpGaD
Deferiprone—Optic neuritis—Cisplatin—esophageal cancer	0.00895	0.0167	CcSEcCtD
Deferiprone—UGT1A6—Biological oxidations—ADH1B—esophageal cancer	0.00806	0.0174	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—ABCC2—esophageal cancer	0.00761	0.0164	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP26A1—esophageal cancer	0.00749	0.0162	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00739	0.0159	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—NFE2L2—esophageal cancer	0.00708	0.0153	CbGpPWpGaD
Deferiprone—Gastric ulcer—Capecitabine—esophageal cancer	0.00698	0.013	CcSEcCtD
Deferiprone—UGT1A6—Biological oxidations—GSTO1—esophageal cancer	0.00696	0.015	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTO1—esophageal cancer	0.00687	0.0148	CbGpPWpGaD
Deferiprone—Infection—Carboplatin—esophageal cancer	0.00665	0.0124	CcSEcCtD
Deferiprone—Nephropathy—Methotrexate—esophageal cancer	0.00634	0.0118	CcSEcCtD
Deferiprone—Furuncle—Methotrexate—esophageal cancer	0.00616	0.0115	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—CYP2A6—esophageal cancer	0.00609	0.0131	CbGpPWpGaD
Deferiprone—Torsade de pointes—Capecitabine—esophageal cancer	0.00579	0.0108	CcSEcCtD
Deferiprone—Hepatomegaly—Capecitabine—esophageal cancer	0.00573	0.0107	CcSEcCtD
Deferiprone—Pain—Carboplatin—esophageal cancer	0.00572	0.0107	CcSEcCtD
Deferiprone—UGT1A6—Biological oxidations—ALDH2—esophageal cancer	0.00568	0.0122	CbGpPWpGaD
Deferiprone—Haemoptysis—Capecitabine—esophageal cancer	0.00548	0.0102	CcSEcCtD
Deferiprone—UGT1A6—Biological oxidations—GSTT1—esophageal cancer	0.0054	0.0117	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP2A6—esophageal cancer	0.00534	0.0115	CbGpPWpGaD
Deferiprone—Body temperature increased—Carboplatin—esophageal cancer	0.00529	0.00986	CcSEcCtD
Deferiprone—UGT1A6—Biological oxidations—PTGS1—esophageal cancer	0.00506	0.0109	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.00463	0.00999	CbGpPWpGaD
Deferiprone—Rectal haemorrhage—Capecitabine—esophageal cancer	0.00449	0.00837	CcSEcCtD
Deferiprone—UGT1A6—Biological oxidations—CYP1B1—esophageal cancer	0.0043	0.00928	CbGpPWpGaD
Deferiprone—Blood bilirubin increased—Capecitabine—esophageal cancer	0.00429	0.008	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—TGFBR2—esophageal cancer	0.00427	0.00921	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00424	0.00916	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—HMOX1—esophageal cancer	0.00421	0.00908	CbGpPWpGaD
Deferiprone—Gait disturbance—Capecitabine—esophageal cancer	0.00416	0.00775	CcSEcCtD
Deferiprone—Pulmonary embolism—Capecitabine—esophageal cancer	0.00406	0.00756	CcSEcCtD
Deferiprone—UGT1A6—Biological oxidations—CYP19A1—esophageal cancer	0.00405	0.00873	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00399	0.00861	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.00395	0.00852	CbGpPWpGaD
Deferiprone—Dehydration—Cisplatin—esophageal cancer	0.00372	0.00693	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.0036	0.00671	CcSEcCtD
Deferiprone—Sepsis—Capecitabine—esophageal cancer	0.00352	0.00656	CcSEcCtD
Deferiprone—Pancreatitis—Cisplatin—esophageal cancer	0.00339	0.00631	CcSEcCtD
Deferiprone—Pancytopenia—Cisplatin—esophageal cancer	0.00328	0.00611	CcSEcCtD
Deferiprone—Increased appetite—Capecitabine—esophageal cancer	0.00313	0.00584	CcSEcCtD
Deferiprone—Atrial fibrillation—Capecitabine—esophageal cancer	0.00311	0.00579	CcSEcCtD
Deferiprone—Arthritis—Capecitabine—esophageal cancer	0.00303	0.00565	CcSEcCtD
Deferiprone—Pulmonary embolism—Methotrexate—esophageal cancer	0.00302	0.00563	CcSEcCtD
Deferiprone—Cardiac failure—Capecitabine—esophageal cancer	0.00302	0.00563	CcSEcCtD
Deferiprone—Diplopia—Capecitabine—esophageal cancer	0.00295	0.00549	CcSEcCtD
Deferiprone—Osteoarthritis—Capecitabine—esophageal cancer	0.00295	0.00549	CcSEcCtD
Deferiprone—Pain in extremity—Capecitabine—esophageal cancer	0.00295	0.00549	CcSEcCtD
Deferiprone—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00291	0.00543	CcSEcCtD
Deferiprone—Dehydration—Capecitabine—esophageal cancer	0.00274	0.00511	CcSEcCtD
Deferiprone—Urinary tract disorder—Cisplatin—esophageal cancer	0.00273	0.00509	CcSEcCtD
Deferiprone—Connective tissue disorder—Cisplatin—esophageal cancer	0.00272	0.00506	CcSEcCtD
Deferiprone—Urethral disorder—Cisplatin—esophageal cancer	0.00271	0.00505	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00265	0.00494	CcSEcCtD
Deferiprone—Sepsis—Methotrexate—esophageal cancer	0.00262	0.00489	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.0026	0.00484	CcSEcCtD
Deferiprone—Eye disorder—Cisplatin—esophageal cancer	0.00258	0.00481	CcSEcCtD
Deferiprone—Cardiac disorder—Cisplatin—esophageal cancer	0.00257	0.00478	CcSEcCtD
Deferiprone—Immune system disorder—Cisplatin—esophageal cancer	0.0025	0.00465	CcSEcCtD
Deferiprone—Mediastinal disorder—Cisplatin—esophageal cancer	0.00249	0.00464	CcSEcCtD
Deferiprone—Pancytopenia—Capecitabine—esophageal cancer	0.00242	0.00451	CcSEcCtD
Deferiprone—Malnutrition—Cisplatin—esophageal cancer	0.00241	0.00448	CcSEcCtD
Deferiprone—Neutropenia—Capecitabine—esophageal cancer	0.00238	0.00444	CcSEcCtD
Deferiprone—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00232	0.00433	CcSEcCtD
Deferiprone—Weight increased—Capecitabine—esophageal cancer	0.00232	0.00432	CcSEcCtD
Deferiprone—Pneumonia—Capecitabine—esophageal cancer	0.00228	0.00426	CcSEcCtD
Deferiprone—Infestation NOS—Capecitabine—esophageal cancer	0.00227	0.00423	CcSEcCtD
Deferiprone—Infestation—Capecitabine—esophageal cancer	0.00227	0.00423	CcSEcCtD
Deferiprone—Jaundice—Capecitabine—esophageal cancer	0.00221	0.00412	CcSEcCtD
Deferiprone—Osteoarthritis—Methotrexate—esophageal cancer	0.00219	0.00409	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—BLVRB—esophageal cancer	0.00217	0.00469	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SLC52A3—esophageal cancer	0.00217	0.00469	CbGpPWpGaD
Deferiprone—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00215	0.004	CcSEcCtD
Deferiprone—Epistaxis—Capecitabine—esophageal cancer	0.00214	0.00399	CcSEcCtD
Deferiprone—Agranulocytosis—Capecitabine—esophageal cancer	0.00212	0.00395	CcSEcCtD
Deferiprone—Convulsion—Cisplatin—esophageal cancer	0.00208	0.00389	CcSEcCtD
Deferiprone—Hepatitis—Capecitabine—esophageal cancer	0.00204	0.0038	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00203	0.00379	CcSEcCtD
Deferiprone—Discomfort—Cisplatin—esophageal cancer	0.00202	0.00377	CcSEcCtD
Deferiprone—Pharyngitis—Capecitabine—esophageal cancer	0.00202	0.00377	CcSEcCtD
Deferiprone—Urinary tract disorder—Capecitabine—esophageal cancer	0.00201	0.00375	CcSEcCtD
Deferiprone—Oedema peripheral—Capecitabine—esophageal cancer	0.00201	0.00374	CcSEcCtD
Deferiprone—Connective tissue disorder—Capecitabine—esophageal cancer	0.002	0.00373	CcSEcCtD
Deferiprone—Urethral disorder—Capecitabine—esophageal cancer	0.002	0.00372	CcSEcCtD
Deferiprone—Anaphylactic shock—Cisplatin—esophageal cancer	0.00196	0.00366	CcSEcCtD
Deferiprone—Infection—Cisplatin—esophageal cancer	0.00195	0.00364	CcSEcCtD
Deferiprone—Nervous system disorder—Cisplatin—esophageal cancer	0.00193	0.00359	CcSEcCtD
Deferiprone—Skin disorder—Cisplatin—esophageal cancer	0.00191	0.00356	CcSEcCtD
Deferiprone—Eye disorder—Capecitabine—esophageal cancer	0.0019	0.00355	CcSEcCtD
Deferiprone—Hyperhidrosis—Cisplatin—esophageal cancer	0.0019	0.00354	CcSEcCtD
Deferiprone—Cardiac disorder—Capecitabine—esophageal cancer	0.00189	0.00352	CcSEcCtD
Deferiprone—Pancreatitis—Methotrexate—esophageal cancer	0.00186	0.00346	CcSEcCtD
Deferiprone—Angiopathy—Capecitabine—esophageal cancer	0.00185	0.00345	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—SLC10A2—esophageal cancer	0.00185	0.00399	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CA1—esophageal cancer	0.00185	0.00399	CbGpPWpGaD
Deferiprone—Immune system disorder—Capecitabine—esophageal cancer	0.00184	0.00343	CcSEcCtD
Deferiprone—Mediastinal disorder—Capecitabine—esophageal cancer	0.00184	0.00342	CcSEcCtD
Deferiprone—Hypotension—Cisplatin—esophageal cancer	0.00183	0.00342	CcSEcCtD
Deferiprone—Chills—Capecitabine—esophageal cancer	0.00183	0.00341	CcSEcCtD
Deferiprone—Pancytopenia—Methotrexate—esophageal cancer	0.0018	0.00335	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00179	0.00333	CcSEcCtD
Deferiprone—Mental disorder—Capecitabine—esophageal cancer	0.00179	0.00333	CcSEcCtD
Deferiprone—Malnutrition—Capecitabine—esophageal cancer	0.00177	0.00331	CcSEcCtD
Deferiprone—Neutropenia—Methotrexate—esophageal cancer	0.00177	0.0033	CcSEcCtD
Deferiprone—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00173	0.00322	CcSEcCtD
Deferiprone—Back pain—Capecitabine—esophageal cancer	0.00172	0.0032	CcSEcCtD
Deferiprone—Decreased appetite—Cisplatin—esophageal cancer	0.00171	0.00318	CcSEcCtD
Deferiprone—Pneumonia—Methotrexate—esophageal cancer	0.0017	0.00317	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.0017	0.00316	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CA2—esophageal cancer	0.00169	0.00365	CbGpPWpGaD
Deferiprone—Infestation—Methotrexate—esophageal cancer	0.00169	0.00315	CcSEcCtD
Deferiprone—Infestation NOS—Methotrexate—esophageal cancer	0.00169	0.00315	CcSEcCtD
Deferiprone—Pain—Cisplatin—esophageal cancer	0.00168	0.00313	CcSEcCtD
Deferiprone—Hepatobiliary disease—Methotrexate—esophageal cancer	0.0016	0.00298	CcSEcCtD
Deferiprone—Epistaxis—Methotrexate—esophageal cancer	0.00159	0.00297	CcSEcCtD
Deferiprone—Agranulocytosis—Methotrexate—esophageal cancer	0.00158	0.00294	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PLCE1—esophageal cancer	0.00157	0.00339	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ADH7—esophageal cancer	0.00157	0.00339	CbGpPWpGaD
Deferiprone—Body temperature increased—Cisplatin—esophageal cancer	0.00155	0.00289	CcSEcCtD
Deferiprone—Hypertension—Capecitabine—esophageal cancer	0.00153	0.00285	CcSEcCtD
Deferiprone—Hepatitis—Methotrexate—esophageal cancer	0.00152	0.00283	CcSEcCtD
Deferiprone—Arthralgia—Capecitabine—esophageal cancer	0.00151	0.00281	CcSEcCtD
Deferiprone—Pharyngitis—Methotrexate—esophageal cancer	0.00151	0.00281	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.0015	0.0028	CcSEcCtD
Deferiprone—Urinary tract disorder—Methotrexate—esophageal cancer	0.0015	0.00279	CcSEcCtD
Deferiprone—Discomfort—Capecitabine—esophageal cancer	0.00149	0.00278	CcSEcCtD
Deferiprone—Urethral disorder—Methotrexate—esophageal cancer	0.00149	0.00277	CcSEcCtD
Deferiprone—Hypersensitivity—Cisplatin—esophageal cancer	0.00145	0.0027	CcSEcCtD
Deferiprone—Infection—Capecitabine—esophageal cancer	0.00144	0.00268	CcSEcCtD
Deferiprone—Nervous system disorder—Capecitabine—esophageal cancer	0.00142	0.00265	CcSEcCtD
Deferiprone—Eye disorder—Methotrexate—esophageal cancer	0.00142	0.00264	CcSEcCtD
Deferiprone—Asthenia—Cisplatin—esophageal cancer	0.00141	0.00263	CcSEcCtD
Deferiprone—Cardiac disorder—Methotrexate—esophageal cancer	0.00141	0.00262	CcSEcCtD
Deferiprone—Skin disorder—Capecitabine—esophageal cancer	0.00141	0.00262	CcSEcCtD
Deferiprone—Hyperhidrosis—Capecitabine—esophageal cancer	0.0014	0.00261	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—ADH1B—esophageal cancer	0.00138	0.00297	CbGpPWpGaD
Deferiprone—Angiopathy—Methotrexate—esophageal cancer	0.00138	0.00257	CcSEcCtD
Deferiprone—Immune system disorder—Methotrexate—esophageal cancer	0.00137	0.00255	CcSEcCtD
Deferiprone—Mediastinal disorder—Methotrexate—esophageal cancer	0.00137	0.00255	CcSEcCtD
Deferiprone—Chills—Methotrexate—esophageal cancer	0.00136	0.00254	CcSEcCtD
Deferiprone—Hypotension—Capecitabine—esophageal cancer	0.00135	0.00252	CcSEcCtD
Deferiprone—Diarrhoea—Cisplatin—esophageal cancer	0.00134	0.0025	CcSEcCtD
Deferiprone—Mental disorder—Methotrexate—esophageal cancer	0.00133	0.00248	CcSEcCtD
Deferiprone—Malnutrition—Methotrexate—esophageal cancer	0.00132	0.00246	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00132	0.00246	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—TYMP—esophageal cancer	0.00132	0.00284	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP26A1—esophageal cancer	0.00128	0.00276	CbGpPWpGaD
Deferiprone—Back pain—Methotrexate—esophageal cancer	0.00128	0.00238	CcSEcCtD
Deferiprone—Dyspepsia—Capecitabine—esophageal cancer	0.00127	0.00238	CcSEcCtD
Deferiprone—Decreased appetite—Capecitabine—esophageal cancer	0.00126	0.00235	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00125	0.00233	CcSEcCtD
Deferiprone—Vomiting—Cisplatin—esophageal cancer	0.00125	0.00233	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—ALOX15—esophageal cancer	0.00125	0.00269	CbGpPWpGaD
Deferiprone—Fatigue—Capecitabine—esophageal cancer	0.00125	0.00233	CcSEcCtD
Deferiprone—Rash—Cisplatin—esophageal cancer	0.00124	0.00231	CcSEcCtD
Deferiprone—Pain—Capecitabine—esophageal cancer	0.00124	0.00231	CcSEcCtD
Deferiprone—Dermatitis—Cisplatin—esophageal cancer	0.00124	0.00231	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GSTO1—esophageal cancer	0.00119	0.00257	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—TPI1—esophageal cancer	0.00119	0.00257	CbGpPWpGaD
Deferiprone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00118	0.00221	CcSEcCtD
Deferiprone—Nausea—Cisplatin—esophageal cancer	0.00117	0.00217	CcSEcCtD
Deferiprone—Urticaria—Capecitabine—esophageal cancer	0.00115	0.00214	CcSEcCtD
Deferiprone—Abdominal pain—Capecitabine—esophageal cancer	0.00114	0.00213	CcSEcCtD
Deferiprone—Body temperature increased—Capecitabine—esophageal cancer	0.00114	0.00213	CcSEcCtD
Deferiprone—Convulsion—Methotrexate—esophageal cancer	0.00114	0.00213	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—ALDOB—esophageal cancer	0.00114	0.00246	CbGpPWpGaD
Deferiprone—Arthralgia—Methotrexate—esophageal cancer	0.00112	0.0021	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00112	0.00208	CcSEcCtD
Deferiprone—Discomfort—Methotrexate—esophageal cancer	0.00111	0.00207	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GAPDH—esophageal cancer	0.0011	0.00237	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CRABP1—esophageal cancer	0.00109	0.00235	CbGpPWpGaD
Deferiprone—Anaphylactic shock—Methotrexate—esophageal cancer	0.00108	0.00201	CcSEcCtD
Deferiprone—Infection—Methotrexate—esophageal cancer	0.00107	0.002	CcSEcCtD
Deferiprone—Hypersensitivity—Capecitabine—esophageal cancer	0.00107	0.00199	CcSEcCtD
Deferiprone—Nervous system disorder—Methotrexate—esophageal cancer	0.00106	0.00197	CcSEcCtD
Deferiprone—Skin disorder—Methotrexate—esophageal cancer	0.00105	0.00195	CcSEcCtD
Deferiprone—Hyperhidrosis—Methotrexate—esophageal cancer	0.00104	0.00194	CcSEcCtD
Deferiprone—Asthenia—Capecitabine—esophageal cancer	0.00104	0.00194	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GNG7—esophageal cancer	0.00104	0.00224	CbGpPWpGaD
Deferiprone—Pruritus—Capecitabine—esophageal cancer	0.00102	0.00191	CcSEcCtD
Deferiprone—Hypotension—Methotrexate—esophageal cancer	0.00101	0.00188	CcSEcCtD
Deferiprone—Diarrhoea—Capecitabine—esophageal cancer	0.00099	0.00185	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000982	0.00183	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—ALDH2—esophageal cancer	0.000971	0.00209	CbGpPWpGaD
Deferiprone—Somnolence—Methotrexate—esophageal cancer	0.000958	0.00179	CcSEcCtD
Deferiprone—Dyspepsia—Methotrexate—esophageal cancer	0.000949	0.00177	CcSEcCtD
Deferiprone—Decreased appetite—Methotrexate—esophageal cancer	0.000937	0.00175	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00093	0.00173	CcSEcCtD
Deferiprone—Fatigue—Methotrexate—esophageal cancer	0.000929	0.00173	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GSTT1—esophageal cancer	0.000924	0.00199	CbGpPWpGaD
Deferiprone—Pain—Methotrexate—esophageal cancer	0.000921	0.00172	CcSEcCtD
Deferiprone—Vomiting—Capecitabine—esophageal cancer	0.00092	0.00172	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP2A6—esophageal cancer	0.000913	0.00197	CbGpPWpGaD
Deferiprone—Rash—Capecitabine—esophageal cancer	0.000913	0.0017	CcSEcCtD
Deferiprone—Dermatitis—Capecitabine—esophageal cancer	0.000912	0.0017	CcSEcCtD
Deferiprone—Headache—Capecitabine—esophageal cancer	0.000907	0.00169	CcSEcCtD
Deferiprone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000881	0.00164	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—ENO1—esophageal cancer	0.000865	0.00187	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTGS1—esophageal cancer	0.000865	0.00187	CbGpPWpGaD
Deferiprone—Nausea—Capecitabine—esophageal cancer	0.00086	0.0016	CcSEcCtD
Deferiprone—Urticaria—Methotrexate—esophageal cancer	0.000856	0.0016	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PSME1—esophageal cancer	0.000853	0.00184	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PSME2—esophageal cancer	0.000853	0.00184	CbGpPWpGaD
Deferiprone—Body temperature increased—Methotrexate—esophageal cancer	0.000852	0.00159	CcSEcCtD
Deferiprone—Abdominal pain—Methotrexate—esophageal cancer	0.000852	0.00159	CcSEcCtD
Deferiprone—Hypersensitivity—Methotrexate—esophageal cancer	0.000794	0.00148	CcSEcCtD
Deferiprone—Asthenia—Methotrexate—esophageal cancer	0.000773	0.00144	CcSEcCtD
Deferiprone—Pruritus—Methotrexate—esophageal cancer	0.000762	0.00142	CcSEcCtD
Deferiprone—Diarrhoea—Methotrexate—esophageal cancer	0.000737	0.00137	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP1B1—esophageal cancer	0.000736	0.00159	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP19A1—esophageal cancer	0.000692	0.00149	CbGpPWpGaD
Deferiprone—Vomiting—Methotrexate—esophageal cancer	0.000685	0.00128	CcSEcCtD
Deferiprone—Rash—Methotrexate—esophageal cancer	0.000679	0.00127	CcSEcCtD
Deferiprone—Dermatitis—Methotrexate—esophageal cancer	0.000679	0.00127	CcSEcCtD
Deferiprone—Headache—Methotrexate—esophageal cancer	0.000675	0.00126	CcSEcCtD
Deferiprone—Nausea—Methotrexate—esophageal cancer	0.00064	0.00119	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—HMOX1—esophageal cancer	0.000631	0.00136	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ABCB1—esophageal cancer	0.000606	0.00131	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CREBBP—esophageal cancer	0.000405	0.000874	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—NOS3—esophageal cancer	0.000363	0.000782	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTGS2—esophageal cancer	0.000332	0.000715	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—EP300—esophageal cancer	0.000276	0.000595	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CA—esophageal cancer	0.000204	0.00044	CbGpPWpGaD
